Omalizumab for Allergic Asthma in Inner-City Children

The News:

MedPage reported this week on a study published this month in the New England Journal of Medicine which found that omalizumab in combination with guideline-based treatment for allergic asthma in inner-city children decreases symptoms, reduces exacerbations, lowers the number of hospitalizations, reduces the need for inhaled controller medications, and reduces seasonal exacerbations.

IDIS Related Question:

Find randomized studies that have evaluated the use of omalizumab for allergic asthma in children.

IDIS Search:

Drug(s): Drug(s): "OMALIZUMAB 82000441"

Disease(s): "ASTHMA, EXTRINSIC 493.0"

Descriptor(s): "STUDY RANDOMIZE PEDIATRIC 136

IDIS Results:

IDIS Articles 639150, 629377, 502981, 491975, and 472262